Klaria Pharma Holding AB (6FN) Ratios
Klaria Pharma Holding AB Ratios
DE:6FN's free cash flow for Q2 2026 was $-14.79M. For the 2026 fiscal year, DE:6FN's free cash flow was increased by $0.00 and operating cash flow was $-14.79M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.05 | 0.05 | 2.29 | 0.93 | 0.58 |
| Quick Ratio | 0.05 | 0.05 | 2.29 | 0.93 | 0.58 |
| Cash Ratio | 0.01 | 0.01 | 0.04 | 0.38 | 0.53 |
| Solvency Ratio | -0.62 | -0.68 | -0.78 | -1.19 | -0.87 |
| Operating Cash Flow Ratio | -0.80 | -0.22 | -0.28 | -1.13 | -0.52 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -0.55 | -0.48 | -3.09 | -0.83 |
| Net Current Asset Value | $ -42.26M | $ -51.11M | $ 41.11M | $ -3.43M | $ -21.09M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.40 | 0.26 | 0.14 | 0.27 |
| Debt-to-Equity Ratio | 0.00 | 6.98 | 0.46 | 0.22 | 0.46 |
| Debt-to-Capital Ratio | 0.00 | 0.87 | 0.32 | 0.18 | 0.31 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -10.50 | 17.32 | 1.77 | 1.58 | 1.70 |
| Debt Service Coverage Ratio | -0.67 | -0.53 | -0.92 | -1.88 | -1.19 |
| Interest Coverage Ratio | -1.49 | -1.90 | -8.65 | -7.01 | -15.83 |
| Debt to Market Cap | 0.00 | 0.52 | 0.41 | 0.24 | 0.09 |
| Interest Debt Per Share | 0.07 | 0.32 | 0.23 | 0.43 | 0.63 |
| Net Debt to EBITDA | 0.04 | -1.12 | -0.85 | -0.01 | -0.16 |
| Profitability Margins | |||||
| Gross Profit Margin | -24.82% | 100.00% | 100.00% | 100.00% | -79.40% |
| EBIT Margin | -226.87% | -1388.21% | -376.73% | -951.45% | -824.26% |
| EBITDA Margin | -102.21% | -889.15% | -246.18% | -763.41% | -644.86% |
| Operating Profit Margin | -226.87% | -1388.21% | -376.73% | -936.84% | -819.85% |
| Pretax Profit Margin | -522.88% | -2123.31% | -423.95% | -1084.82% | -876.06% |
| Net Profit Margin | -432.22% | -2124.11% | -423.28% | -1086.81% | -875.88% |
| Continuous Operations Profit Margin | -522.88% | -2124.11% | -217.47% | -1086.81% | -875.88% |
| Net Income Per EBT | 82.66% | 100.04% | 99.84% | 100.18% | 99.98% |
| EBT Per EBIT | 230.48% | 152.95% | 112.53% | 115.79% | 106.86% |
| Return on Assets (ROA) | -95.42% | -83.38% | -49.05% | -53.03% | -45.25% |
| Return on Equity (ROE) | 1002.32% | -1443.91% | -87.00% | -83.83% | -77.12% |
| Return on Capital Employed (ROCE) | 625.94% | -795.29% | -77.43% | -71.93% | -71.14% |
| Return on Invested Capital (ROIC) | 625.94% | -118.32% | -52.94% | -59.01% | -49.53% |
| Return on Tangible Assets | -1304.06% | -1104.56% | -49.05% | -152.47% | -181.32% |
| Earnings Yield | -31.53% | -114.38% | -77.92% | -94.62% | -15.70% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.39 | 1.10 | 4.98 | 0.25 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 1.27 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | -783.21 |
| Fixed Asset Turnover | 15.23 | 1.53 | 313.11 | 5.49 | 3.55 |
| Asset Turnover | 0.22 | 0.04 | 0.12 | 0.05 | 0.05 |
| Working Capital Turnover Ratio | -0.20 | -0.48 | 0.44 | -0.51 | -1.24 |
| Cash Conversion Cycle | 83.14 | 330.42 | -92433.95 | 1480.09 | -287.77 |
| Days of Sales Outstanding | 83.14 | 330.42 | 73.27 | 1480.09 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | -0.47 |
| Days of Payables Outstanding | 0.00 | 0.00 | 92507.22 | 0.00 | 287.31 |
| Operating Cycle | 83.14 | 330.42 | 73.27 | 1480.09 | -0.47 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.19 | -0.10 | -0.09 | -0.86 | -0.45 |
| Free Cash Flow Per Share | -0.19 | -0.10 | -0.03 | -0.86 | -0.45 |
| Dividend Paid and CapEx Coverage Ratio | -1.00 | 0.00 | 0.00 | -1184.02 | 0.00 |
| Capital Expenditure Coverage Ratio | -1.00 | 0.00 | 0.00 | -1184.02 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | -0.52 | -0.48 | -2.91 | -0.78 |
| Operating Cash Flow to Sales Ratio | -3.89 | -5.31 | -1.07 | -8.47 | -4.06 |
| Free Cash Flow Yield | -28.40% | -28.59% | -7.33% | -73.85% | -7.27% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.17 | -0.88 | -1.28 | -1.06 | -6.37 |
| Price-to-Sales (P/S) Ratio | 13.71 | 18.57 | 5.43 | 11.49 | 55.78 |
| Price-to-Book (P/B) Ratio | -31.79 | 12.62 | 1.12 | 0.89 | 4.91 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.52 | -3.50 | -13.64 | -1.35 | -13.75 |
| Price-to-Operating Cash Flow Ratio | -3.52 | -3.50 | -5.07 | -1.36 | -13.75 |
| Price-to-Earnings Growth (PEG) Ratio | 0.07 | -0.16 | 0.02 | -0.08 | 0.50 |
| Enterprise Value Multiple | -13.37 | -3.21 | -3.06 | -1.51 | -8.81 |
| Enterprise Value | 123.03M | 64.22M | 63.61M | 67.72M | 347.14M |
| EV to EBITDA | -13.37 | -3.21 | -3.06 | -1.51 | -8.81 |
| EV to Sales | 13.67 | 28.57 | 7.52 | 11.54 | 56.80 |
| EV to Free Cash Flow | -3.51 | -5.38 | -18.89 | -1.36 | -14.00 |
| EV to Operating Cash Flow | -3.51 | -5.38 | -7.02 | -1.36 | -14.00 |
| Tangible Book Value Per Share | -0.22 | -0.40 | 0.41 | -0.04 | -0.35 |
| Shareholders’ Equity Per Share | -0.02 | 0.03 | 0.41 | 1.31 | 1.26 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.00 | 0.00 | -0.00 | 0.00 |
| Revenue Per Share | 0.05 | 0.02 | 0.09 | 0.10 | 0.11 |
| Net Income Per Share | -0.21 | -0.38 | -0.36 | -1.10 | -0.97 |
| Tax Burden | 0.83 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 2.30 | 1.53 | 1.13 | 1.14 | 1.06 |
| Research & Development to Revenue | 2.23 | 9.83 | 2.95 | 8.75 | 10.39 |
| SG&A to Revenue | 1.57 | 5.08 | 1.67 | 1.34 | 1.23 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.90 | 0.25 | 0.49 | 0.90 | 0.49 |
Currency in SEK